Ralph H. Thurman's most recent trade in Outlook Therapeutics Inc was a trade of 5,000 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on May 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Purchase of securities on an exchange or from another person at price $ 0.43 per share. | 26 May 2026 | 5,000 | 5,593 (0%) | 0% | 0.4 | 2,145 | Common Stock |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 286,734 | 286,734 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 89,549 | 89,549 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 56,636 | 56,636 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 94,441 | 94,441 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Tff Pharmaceuticals Inc | Ralph H. Thurman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2022 | 40,255 | 84,670 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Ralph H. Thurman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 29 Sep 2022 | 40,255 | 40,255 (0%) | 0% | 2.5 | 100,638 | Common Stock |
| Tff Pharmaceuticals Inc | Ralph H. Thurman | Director | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 29 Sep 2022 | 40,255 | 0 (0%) | 0% | 4.3 | 172,694 | Common Stock |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 81,878 | 81,878 | - | - | Stock Option (Right to Buy) |